News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
700,500 Results
Type
Article (40777)
Company Profile (252)
Press Release (659471)
Section
Business (204979)
Career Advice (2102)
Deals (35533)
Drug Delivery (95)
Drug Development (81579)
Employer Resources (172)
FDA (16235)
Job Trends (14919)
News (346778)
Policy (32728)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (5)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2598)
Accelerated approval (2)
Adcomms (24)
Allergies (80)
Alliances (49772)
ALS (86)
Alzheimer's disease (1361)
Antibody-drug conjugate (ADC) (112)
Approvals (16232)
Artificial intelligence (235)
Autoimmune disease (16)
Automation (14)
Bankruptcy (360)
Best Places to Work (11692)
BIOSECURE Act (18)
Biosimilars (102)
Biotechnology (180)
Bladder cancer (59)
Brain cancer (26)
Breast cancer (254)
Cancer (2036)
Cardiovascular disease (164)
Career advice (1749)
Career pathing (29)
CAR-T (142)
Cell therapy (406)
Cervical cancer (19)
Clinical research (66073)
Collaboration (770)
Compensation (455)
Complete response letters (20)
COVID-19 (2615)
CRISPR (37)
C-suite (211)
Cystic fibrosis (98)
Data (1976)
Decentralized trials (2)
Denatured (28)
Depression (39)
Diabetes (249)
Diagnostics (6395)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (112)
Drug pricing (98)
Drug shortages (25)
Duchenne muscular dystrophy (88)
Earnings (86317)
Editorial (33)
Employer branding (21)
Employer resources (146)
Events (112223)
Executive appointments (651)
FDA (17354)
Featured Employer (48)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (689)
Gene editing (99)
Generative AI (18)
Gene therapy (291)
GLP-1 (690)
Government (4427)
Grass and pollen (4)
Guidances (48)
Healthcare (18933)
Huntington's disease (22)
IgA nephropathy (23)
Immunology and inflammation (105)
Indications (26)
Infectious disease (2746)
Inflammatory bowel disease (134)
Inflation Reduction Act (8)
Influenza (47)
Intellectual property (88)
Interviews (343)
IPO (16532)
IRA (40)
Job creations (3649)
Job search strategy (1482)
Kidney cancer (9)
Labor market (34)
Layoffs (460)
Leadership (15)
Legal (7947)
Liver cancer (71)
Lung cancer (297)
Lymphoma (135)
Machine learning (4)
Management (58)
Manufacturing (270)
MASH (61)
Medical device (13343)
Medtech (13348)
Mergers & acquisitions (19476)
Metabolic disorders (633)
Multiple sclerosis (71)
NASH (17)
Neurodegenerative disease (81)
Neuropsychiatric disorders (24)
Neuroscience (1845)
NextGen: Class of 2025 (6566)
Non-profit (4526)
Northern California (2438)
Now hiring (37)
Obesity (341)
Opinion (209)
Ovarian cancer (73)
Pain (77)
Pancreatic cancer (78)
Parkinson's disease (136)
Partnered (20)
Patents (206)
Patient recruitment (93)
Peanut (46)
People (57337)
Pharmaceutical (63)
Pharmacy benefit managers (19)
Phase I (20617)
Phase II (29098)
Phase III (21677)
Pipeline (1045)
Podcasts (58)
Policy (112)
Postmarket research (2571)
Preclinical (8780)
Press Release (72)
Prostate cancer (94)
Psychedelics (31)
Radiopharmaceuticals (248)
Rare diseases (364)
Real estate (5920)
Recruiting (65)
Regulatory (22310)
Reports (46)
Research institute (2360)
Resumes & cover letters (355)
Rett syndrome (3)
RNA editing (4)
RSV (39)
Schizophrenia (64)
Series A (121)
Series B (79)
Service/supplier (11)
Sickle cell disease (51)
Southern California (2109)
Special edition (15)
Spinal muscular atrophy (150)
Sponsored (28)
Startups (3600)
State (2)
Stomach cancer (14)
Supply chain (59)
The Weekly (28)
United States (21293)
Vaccines (674)
Venture capitalists (37)
Webinars (12)
Weight loss (225)
Women's health (35)
Worklife (16)
Date
Today (167)
Last 7 days (749)
Last 30 days (2831)
Last 365 days (33843)
2025 (8171)
2024 (35457)
2023 (40299)
2022 (51455)
2021 (55956)
2020 (54304)
2019 (46841)
2018 (35295)
2017 (32361)
2016 (31691)
2015 (37756)
2014 (31495)
2013 (26535)
2012 (28732)
2011 (29445)
2010 (27456)
Location
Africa (732)
Alabama (50)
Alaska (7)
Arizona (226)
Arkansas (14)
Asia (38086)
Australia (6245)
California (5558)
Canada (1881)
China (476)
Colorado (250)
Connecticut (257)
Delaware (128)
Europe (82035)
Florida (824)
Georgia (195)
Idaho (57)
Illinois (500)
India (23)
Indiana (293)
Iowa (9)
Japan (142)
Kansas (101)
Kentucky (23)
Louisiana (7)
Maine (60)
Maryland (829)
Massachusetts (4190)
Michigan (209)
Minnesota (370)
Mississippi (2)
Missouri (78)
Montana (27)
Nebraska (25)
Nevada (57)
New Hampshire (62)
New Jersey (1594)
New Mexico (29)
New York (1595)
North Carolina (930)
North Dakota (7)
Northern California (2438)
Ohio (191)
Oklahoma (14)
Oregon (33)
Pennsylvania (1266)
Puerto Rico (9)
Rhode Island (26)
South America (1111)
South Carolina (18)
South Dakota (1)
Southern California (2109)
Tennessee (93)
Texas (829)
Utah (166)
Virginia (130)
Washington D.C. (57)
Washington State (515)
West Virginia (3)
Wisconsin (49)
700,500 Results for "express scripts inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Express Scripts Sues FTC, Demands Withdrawal of ‘False and Misleading’ PBM Report
Pharmacy benefit manager Express Scripts announced Tuesday it has filed a lawsuit in federal court in Missouri against the Federal Trade Commission for its “unfair, biased and erroneous” July report on the industry.
September 17, 2024
·
2 min read
·
Kate Goodwin
BioMidwest
Express Scripts enhances strategies to support access to care at independent pharmacies
Express Scripts, the pharmacy benefits services business of The Cigna Group’s Evernorth, is making it easier for people to access a broader range of care services at independent pharmacies.
May 23, 2024
·
3 min read
Pharm Country
Phathom Pharmaceuticals Announces VOQUEZNA® (vonoprazan) Tablets for Erosive GERD and Associated Heartburn Added to Express Scripts National Formularies for Commercial Patients
Phathom Pharmaceuticals, Inc. today announced the placement of VOQUEZNA® (vonoprazan) tablets for the treatment of adults with Erosive Esophagitis, commonly referred to as Erosive GERD (gastroesophageal reflux disease), and relief of heartburn associated with Erosive Esophagitis on the Express Scripts national formularies, effective immediately.
February 13, 2024
·
11 min read
Lone Star Bio
INPEFA® (Sotagliflozin) Receives Preferred Formulary Status With Express Scripts For Medicare Patients
Lexicon Pharmaceuticals, Inc. announced that Express Scripts, the pharmacy benefits management business of The Cigna Group’s Evernorth, has determined that it will place INPEFA on its Premier Access and Premier Performance national formularies for Medicare patients on November 1, 2023.
October 9, 2023
·
9 min read
Lone Star Bio
INPEFA® (Sotagliflozin) Receives Coverage From Express Scripts on Its Basic and High Performance Formularies for Commercially Insured Patients
Lexicon Pharmaceuticals, Inc. announced that Express Scripts, the pharmacy benefits management business of The Cigna Group’s Evernorth, has determined that it will place INPEFA on its Basic and High Performance formularies for commercially insured patients as of, November 1, 2023, and in addition to the previously reported Premier Access and Premier Performance national formularies for Medicare patients.
November 1, 2023
·
9 min read
Press Releases
DNAnexus Announces Collaboration with AlidaBio to Enhance RNA Modification and Expression Analysis
March 24, 2025
·
4 min read
BioMidwest
Express Scripts Adds Three Biosimilars to Largest Formulary to Promote Competition and Advance Affordability, Choices for Patients
Express Scripts announced that as part of its commitment to driving greater affordability for clients and people living with inflammatory conditions, it will add three additional biosimilars to its National Preferred Formulary.
July 10, 2023
·
4 min read
Press Releases
Celltrion USA partners with Express Scripts and Cigna Healthcare to expand access to ZYMFENTRA® (infliximab-dyyb), the first and only FDA-approved subcutaneous infliximab on their medical benefit formulary
August 29, 2024
·
11 min read
Press Releases
Twist Bioscience Offers Clonal Genes for Global Academic Researchers at Express Speed for No Extra Cost
March 11, 2025
·
2 min read
Biotech Beach
Arcutis’ ZORYVE® (Roflumilast) Cream 0.3% Added to Express Scripts, Inc.® National Formularies in the United States
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), an early-stage commercial company focused on developing meaningful innovations in immuno-dermatology, today announced that ZORYVE® (roflumilast) cream 0.3% for the treatment of plaque psoriasis in adults and adolescents is now on Express Scripts national formularies for commercial benefit plans, effective November 18.
November 17, 2022
·
4 min read
1 of 70,050
Next
